Debulking Atherectomy in the Peripheral Arteries: Is There a Role and What is the Evidence?

CardioVascular and Interventional Radiology

Volumn 40, Issue 7, 2017, Pages 964-977

  Katsanos, Konstantinos ^a,c   Spiliopoulos, Stavros ^b   Reppas, Lazaros ^b   Karnabatidis, Dimitris ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Amputation; Atherectomy; Atherosclerosis; Directional; Embolization; Laser; Patency; Plaque excision; Rotational

Indexed keywords

NITINOL;

ARTICLE; ATHERECTOMY; ATHERECTOMY CATHETER; BALLOON; CATHETER; CLINICAL OUTCOME; CLINICAL PRACTICE; CYTOREDUCTIVE SURGERY; DIRECTIONAL ATHERECTOMY; ENDOVASCULAR SURGERY; EXCIMER LASER; GUIDE WIRE; HUMAN; LASER ATHERECTOMY; LIMB SALVAGE; ORBITAL ATHERECTOMY; ORBITAL ATHERECTOMY DEVICE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; ROTATIONAL ATHERECTOMY; THROMBECTOMY DEVICE; ALGORITHM; DEVICES; EQUIPMENT DESIGN; FEMORAL ARTERY; PERIPHERAL VASCULAR DISEASE; STENT; VASCULAR PATENCY;

ALGORITHMS; ATHERECTOMY; CYTOREDUCTION SURGICAL PROCEDURES; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; FEMORAL ARTERY; HUMANS; LIMB SALVAGE; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; VASCULAR PATENCY;

EID: 85018361139     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-017-1649-6     Document Type: Article

References (38)

1. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–26.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–41.
3. Hussein AA, Uno K, Wolski K, et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol. 2011;57(10):1220–5.
4. Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Interv Radiol. 2014;37(3):592–603.
5. Shammas NW. An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors. Int J Angiol. 2013;22(1):1–8.
6. Karnabatidis D, Katsanos K, Spiliopoulos S, Diamantopoulos A, Kagadis GC, Siablis D. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. J Endovasc Ther. 2009;16(1):15–22.
7. Laird JR. Endovascular treatment of common femoral artery disease viable alternative to surgery or just another short-term fix. J Am Coll Cardiol. 2011;58(8):799–800.
8. Mittleider D, Russell E. Peripheral atherectomy: applications and techniques. Tech Vasc Interv Radiol. 2016;19(2):123–35.
9. Akkus NI, Abdulbaki A, Jimenez E, Tandon N. Atherectomy devices: technology update. Med Devices (Auckl). 2015;8:1–10.
10. Cawich I, Paixao AR, Marmagkiolis K, et al. Immediate and intermediate-term results of optical coherence tomography guided atherectomy in the treatment of peripheral arterial disease: initial results from the VISION trial. Cardiovasc Revasc Med. 2016;17(7):463–7.
11. Karnabatidis D, Katsanos K, Kagadis GC, et al. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther. 2006;13(3):269–80.
12. Grundfest WS, Litvack F, Forrester JS, et al. Laser ablation of human atherosclerotic plaque without adjacent tissue injury. J Am Coll Cardiol. 1985;5(4):929–33.
13. Shammas NW, Coiner D, Shammas GA, Dippel EJ, Christensen L, Jerin M. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol. 2011;22(9):1223–8.
14. Shammas NW, Lam R, Mustapha J, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther. 2012;19(4):480–8.
15. Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014;26(8):355–60.
16. Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer laser randomized controlled study for treatment of femoropopliteal in-stent restenosis). JACC Cardiovasc Interv. 2015;8:92–101 (1 Pt A).
17. Diamantopoulos A, Katsanos K. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino). 2014;55(5):655–65.
18. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON registry: treating peripherals with SilverHawk—outcomes collection. J Endovasc Ther. 2006;13(5):592–602.
19. McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA, Investigators DL. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7(8):923–33.
20. Garcia LA, Jaff MR, Rocha-Singh KJ, et al. A comparison of clinical outcomes for diabetic and nondiabetic patients following directional atherectomy in the DEFINITIVE LE Claudicant cohort. J Endovasc Ther. 2015;22(5):701–11.
21. Rastan A, McKinsey JF, Garcia LA, et al. 1-year outcomes following directional atherectomy of infrapopliteal artery lesions: subgroup results of the prospective, multicenter DEFINITIVE LE trial. J Endovasc Ther. 2015;22(6):839–46.
22. Roberts D, Niazi K, Miller W, et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca(+)(+) trial. Catheter Cardiovasc Interv. 2014;84(2):236–44.
23. Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. 2006;48(8):1573–8.
24. Zeller T, Krankenberg H, Steinkamp H, et al. 1-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther. 2009;16(6):653–62.
25. Beschorner U, Krankenberg H, Scheinert D, et al. Rotational and aspiration atherectomy for infrainguinal in-stent restenosis. Vasa. 2013;42(2):127–33.
26. Mehta M, Zhou Y, Paty PS, et al. Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting. J Vasc Surg. 2016;64(2):369–79.
27. Safian RD, Niazi K, Runyon JP, et al. Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv. 2009;73(3):406–12.
28. Laird JR, Zeller T, Gray BH, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13(1):1–11.
29. Scheinert D, Laird JR Jr, Schroder M, Steinkamp H, Balzer JO, Biamino G. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther. 2001;8(2):156–66.
30. Shammas NW, Coiner D, Shammas GA, Christensen L, Dippel EJ, Jerin M. Distal embolic event protection using excimer laser ablation in peripheral vascular interventions: results of the DEEP EMBOLI registry. J Endovasc Ther. 2009;16(2):197–202.
31. Dave RM, Patlola R, Kollmeyer K, et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009;16(6):665–75.
32. Laird JR Jr, Yeo KK, Rocha-Singh K, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: 12-month results from the SALVAGE study. Catheter Cardiovasc Interv. 2012;80(5):852–9.
33. Todd KE Jr, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg. 2013;58(4):941–8.
34. Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D. Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23(2):356–70.
35. Katsanos K, Kitrou P, Spiliopoulos S, Diamantopoulos A, Karnabatidis D. Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery disease: systematic review and Bayesian network meta-analysis of randomized controlled trials. J Endovasc Ther. 2016;23(6):851–63.
36. Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg. 2014;59(4):1123–33 (e1128).
37. Cioppa A, Stabile E, Popusoi G, et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: 1-year single centre clinical results. Cardiovasc Revasc Med. 2012;13(4):219–23.
38. Shammas NW, Dippel EJ, Coiner D, Shammas GA, Jerin M, Kumar A. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther. 2008;15(3):270–6.